Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE2325.0513.8 (+0.6 %)

PREV CLOSE ( ) 2311.25

OPEN PRICE ( ) 2335.00

BID PRICE (QTY) 2325.25 (18)

OFFER PRICE (QTY) 2345.90 (8)

VOLUME 5812

TODAY'S LOW / HIGH ( )2311.00 2375.00

52 WK LOW / HIGH ( ) 707.92620

NSE

This Company is not listed in NSE

Select year

(Rs.in Million)

Particulars

Mar 2026

Mar 2025

Profit Before Tax

346.85

274.94

Adjustment

461.58

275.93

Changes In working Capital

-689.41

-716.84

Cash Flow after changes in Working Capital

119.02

-165.98

Cash Flow from Operating Activities

119.02

-165.98

Cash Flow from Investing Activities

-735.91

-63.54

Cash Flow from Financing Activities

1214.47

266.51

Net Cash Inflow / Outflow

597.58

36.99

Opening Cash & Cash Equivalents

52.23

15.24

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

649.81

52.23